CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a ...

LTR Pharma signs deal with pharmaceutical wholesaler Symbion for erectile dysfunction treatment Spontan. ... Read More The ...

Amid opioid overdoses and deaths, the Fall River School Committee voted to teach high school students how to give people Narcan.

its novel nasal spray treatment for erectile dysfunction. LTR Pharma (ASX:LTP) said under the deal Symbion would provide warehousing, inventory management and nationwide distribution services for ...